Category VIEW ALL
Netrin-1 and UNC5B as Novel Targets in Metabolic Liver Diseases: NAFLD & NASH
Technology No. MOO02-06
Chimeric FGF21: Treatment of NAFLD, NASH and Hepatic Steatosis
Technology No. MOH01-03